Finance

Lists
187660:KOSDAQ
Penetrium Bioscience Inc
â‚©5,850.00
+14.71%
(+750.00) 1D
Sep 4, 3:30:17 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 187660...
Open
â‚©5,120
High
â‚©5,850
Low
â‚©4,290
Mkt. cap
374.20B
Avg. vol.
1.05M
Volume
4.10M
52-wk high
â‚©20,312
52-wk low
â‚©2,173
EPS
-â‚©313
Shares outstanding
63.97M
No. of employees
113
Open
â‚©5,120
High
â‚©5,850
Low
â‚©4,290
Mkt. cap
374.20B
Avg. vol.
1.05M
Volume
4.10M
52-wk high
â‚©20,312
52-wk low
â‚©2,173
EPS
-â‚©313
Shares outstanding
63.97M
No. of employees
113
About Penetrium Bioscience Inc
CEOJong-Eon Lim
Employees113
Founded2003
Headquarters-
SectorHealth care
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Jun 2024
Sep 2024
Dec 2024
Revenue
2.63B
2.04B
-
Cost of goods sold
2.39B
2.29B
-
Cost of revenue
2.39B
2.29B
-
Research and development expenses
9.33B
1.03B
-
Total research and development expenses
-
-
-
Selling, general, and admin expenses
1.19B
987.24M
-
Operating expense
10.80B
2.33B
-
Total operating expenses
13.19B
4.62B
-
Operating income
-10.57B
-2.58B
-
Other non operating income
-2.16B
-79.27M
-
EBT including unusual items
-12.67B
-3.79B
-
EBT excluding unusual items
-12.56B
-3.03B
-
Income tax expense
54.99M
-
-
Effective tax rate
-0.43%
-
-
Other operating expenses
30.78M
41.01M
-
Net income
-12.48B
-3.57B
-
Net profit margin
-475.14%
-174.38%
-
Earnings per share
-
-
-
Interest and investment income
213.71M
70.18M
-
Interest expense
-73.78M
-448.74M
-
Net interest expenses
139.93M
-378.56M
-
Depreciation and amortization charges
208.24M
234.15M
-
EBITDA
-10.15B
-2.18B
-
Gain or loss from assets sale
-
742.90M
-
AI content may include mistakes. Learn more
Google apps